Hypertrophic Pulmonary Osteoarthropathy Associated with Non-small Cell Lung Cancer Demonstrated Growth Hormone-Releasing Hormone by Immunohistochemical Analysis.

Katsuhiko Mito, Riichiroh Maruyama, Y Uenishi, Kazuhiro Arita, Hiroshi Kawano, Kenji Kashima, Masaru NasuInternal 2001 · DOI

Introduction

Hypertrophic Pulmonary Osteoarthropathy (HPO) is a paraneoplastic syndrome characterized by a triad of digital clubbing, arthritis, and periostitis of long bones. While frequently associated with lung malignancies, the underlying pathophysiology remains a subject of debate, with theories alternating between neurogenic (vagal) and humoral (hormonal) triggers. This case report investigates a 58-year-old male with non-small cell lung cancer (NSCLC) and HPO, providing compelling evidence for a humoral mechanism involving the growth hormone-releasing hormone (GHRH)-growth hormone (GH) axis.

Clinical Presentation and Methods

A 58-year-old man presented with a large mass in the right lung, identified via chest X-ray and CT scan. Concurrently, he exhibited severe arthralgia, extremity swelling, and finger clubbing. To investigate the systemic nature of these symptoms, the clinical team utilized:

  • Imaging: Bone scintigraphy was performed to map the extent of periostitis.
  • Endocrine Profiling: Serum levels of GH and other pituitary hormones were measured.
  • Immunohistochemical (IHC) Analysis: Post-resection, the tumor tissue was analyzed for the presence of GHRH and GH to pinpoint the source of hormonal elevation.

Key Insights: The GHRH-GH Axis

The pivotal finding in this case was the tumor's hormonal profile. IHC analysis revealed that the adenocarcinoma was positive for GHRH but negative for GH. This indicates that the tumor was not producing growth hormone directly; instead, it was secreting GHRH, which acted as an ectopic "master switch," stimulating the patient's own pituitary gland to overproduce GH.

IHC analysis of the tumor tissue showing GHRH expression.

This mechanism explains the elevated fasting serum GH levels (0.74 ng/ml) observed pre-operatively. The localization of GHRH to undifferentiated components of the tumor suggests that less-specialized cancer cells may be more prone to such endocrine "hijacking."

Results and Resolution

Following a right lower lobectomy, the patient's symptoms showed a dramatic and rapid reversal. The severe joint pain and swelling disappeared within days. Post-operative endocrine testing confirmed that serum GH levels had returned to the normal range.

Bone scintigraphy showing characteristic HPO "hot spots" in long bones and their resolution post-surgery.

Follow-up bone scintigraphy two months later demonstrated nearly complete resolution of the abnormal uptake in the femoral and tibial shafts, correlating with the clinical recovery. The tumor was staged as a T2 N0 M0 (Stage IB) adenocarcinoma.

Conclusion

This case represents only the second reported instance of GHRH-producing NSCLC associated with HPO. The immediate resolution of symptoms following tumor removal, paired with the normalization of GH levels and the IHC confirmation of ectopic GHRH, strongly supports the humoral theory of HPO. While HPO is likely multifactorial, this study highlights the GHRH-GH axis as a significant contributing factor in specific paraneoplastic presentations.

Summary updated

Abstract

Hypertrophic pulmonary osteoarthropathy (HPO) associated with non-small cell lung cancer in a 58-year-old man was accompanied by an elevated serum level of growth hormone (GH). HPO rapidly disappeared after resection of the primary tumor and the elevation of serum GH was resolved. Immunohistochemically the tumor contained growth hormone-releasing hormone (GHRH) but not GH. These findings suggest that the high serum GH level due to ectopic GHRH production in the tumor, was a contributing factor in HPO. This is the second reported case of non-small cell lung cancer which was immunohistochemically positive for GHRH associated with HPO.
BibTeX
@inproceedings{mito2001hypertrophic,
  author = {Katsuhiko Mito and Riichiroh Maruyama and Y Uenishi and Kazuhiro ARITA and Hiroshi Kawano and Kenji Kashima and Masaru Nasu},
  title = {{Hypertrophic Pulmonary Osteoarthropathy Associated with Non-small Cell Lung Cancer Demonstrated Growth Hormone-Releasing Hormone by Immunohistochemical Analysis.}},
  booktitle = {Internal},
  year = {2001},
  doi = {10.2169/internalmedicine.40.532},
}
Figure